{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["121(31)"],"submitter":["Pandey S"],"pubmed_abstract":["Current treatments of anxiety and depressive disorders are plagued by considerable side effects and limited efficacies, underscoring the need for additional molecular targets that can be leveraged to improve medications. Here, we have identified a molecular cascade triggered by chronic stress that exacerbates anxiety- and depressive-like behaviors. Specifically, chronic stress enhances Src kinase activity and tyrosine phosphorylation of calmodulin, which diminishes MyosinVa (MyoVa) interaction with Neuroligin2 (NL2), resulting in decreased inhibitory transmission and heightened anxiety-like behaviors. Importantly, pharmacological inhibition of Src reinstates inhibitory synaptic deficits and effectively reverses heightened anxiety-like behaviors in chronically stressed mice, a process requi"],"journal":["Proceedings of the National Academy of Sciences of the United States of America"],"pagination":["e2400078121"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11295078"],"repository":["biostudies-literature"],"pubmed_title":["Reversing anxiety by targeting a stress-responsive signaling pathway."],"pmcid":["PMC11295078"],"pubmed_authors":["Wu K","Li Y","Li J","Castellano D","Lu W","Han W","Dong L","Pandey S","Shepard R","Tian Q"],"additional_accession":[]},"is_claimable":false,"name":"Reversing anxiety by targeting a stress-responsive signaling pathway.","description":"Current treatments of anxiety and depressive disorders are plagued by considerable side effects and limited efficacies, underscoring the need for additional molecular targets that can be leveraged to improve medications. Here, we have identified a molecular cascade triggered by chronic stress that exacerbates anxiety- and depressive-like behaviors. Specifically, chronic stress enhances Src kinase activity and tyrosine phosphorylation of calmodulin, which diminishes MyosinVa (MyoVa) interaction with Neuroligin2 (NL2), resulting in decreased inhibitory transmission and heightened anxiety-like behaviors. Importantly, pharmacological inhibition of Src reinstates inhibitory synaptic deficits and effectively reverses heightened anxiety-like behaviors in chronically stressed mice, a process requi","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Jul","modification":"2025-04-26T03:57:58.744Z","creation":"2025-04-06T10:57:41.199Z"},"accession":"S-EPMC11295078","cross_references":{"pubmed":["39058580"],"doi":["10.1073/pnas.2400078121"]}}